External factors at play right now which is unfortunate for...

External factors at play right now which is unfortunate for holders.
However, IMO it's irrelevant whether there is or isn't another order from the US government. Of course it would be amazing for Bubs to strike another deal, but the fact is that Bubs is one of very few companies that has been FDA approved and endorsed by Biden as a safe, reliable and trusted brand. The brand awareness this has created for Bubs is priceless.
Over the next few months, Bubs will be on shelves across the largest retailers in America and will provide families with comfort and more importantly infants with the nutrients they need. These new relationships with the big retailers and their customers is what's important moving forward in the US market.
IMO what's more relevant is whether legislative changes occur. The US formula market will simply need to diversify and not be 90% controlled by 4 US companies. The formula shortage is a huge issue over there right now and the US government is under enormous stress to make the necessary changes to ensure this crisis will never happen again. The only way to do this is by removing high tariffs and allow formula importation to continue for FDA approved products.

I strongly believe this unique opportunity for Bubs has been overlooked by the market and overshadowed by the current macro environment.